Roivant Won’t Continue With Brepocitinib In Lupus After Phase II Failure

 
• By Joseph Haas
  
Juggling
Without SLE, Roivant has fewer indications to juggle now with brepocitinib • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D